Our primary focus at Milestone is preparing for potential FDA approval of CARDAMYST nasal spray for the management of PSVT,” said ...

The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and provided ...

The global Nasal Drug Delivery Technology Market is expected to grow from approximately USD 4.4 billion in 2024 to around USD 7.8 billion by 2031, achieving a compound annual growth rate (CAGR) of ...

SoundHealth, Inc. ("SoundHealth"), a medical technology company harnessing the power of artificial intelligence and medical ...

Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...

“Our primary focus at Milestone is preparing for potential FDA approval of CARDAMYST nasal spray for the management of PSVT,” said Joseph Oliveto, President and Chief Executive Officer of Milestone ...

Sinus infections can cause discomfort and congestion. Following some home remedies can help treat a sinus infection and ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...

Among the latest innovations are tanning nasal sprays and Permatan—two methods that have been generating buzz in the beauty ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.